Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | Director · PRESIDENT, CEO AND DIRECTOR | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 25,499.2826 |
Reported balance
After 2026-10-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 127.6843 · Balance 25,499.2826 F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date December 31, 2018 · Filed February 01, 2019
Section 16 reporting ended · disclosed 2019-02-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,258 |
Reported balance
After 2018-03-13 transaction · row 1
1 source rowRow 1 · 2018-03-13 · Gift · Disposed 3,200 · Balance 132,258 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,093 |
Reported balance
Holding disclosure · report date 2018-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,093 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2025 Filed Mar 5, 2025 23:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units (Match) · Derivative | 14,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007082 · form4-03052025_110334.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,891 Underlying: Common Stock · 14,891 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F4 · derivative.exercise_date: Deferred stock units vest December 31, 2026 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. F4 · derivative.expiration_date: Deferred stock units vest December 31, 2026 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 556,587 | $0.00 Strike: $11.31 | $0.00 |
DisclosureSEC source: 0001415889-25-007082 · form4-03052025_110334.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 556,587 Underlying: Common Stock · 556,587 shares Expires 2035-03-03 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 265,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007082 · form4-03052025_110334.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,802,379 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 75,721 | $11.17 | $845,803.57 |
DisclosureSEC source: 0001415889-25-006627 · form4-03042025_100302.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,537,127 Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:43 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 251.2922 | $11.02 | $2,769.24 |
DisclosureSEC source: 0001415889-25-005516 · form4-02252025_090200.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,955.7313 Underlying: Common Stock · 251.2922 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 195,840 | $11.24 | $2,201,241.60 |
DisclosureSEC source: 0001415889-25-005164 · form4-02212025_110211.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,612,848 Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 449,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005164 · form4-02212025_110211.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,808,688 F1 · balance_after: Corrects the number of shares purchased under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022, June 30, 2023 and April 30, 2024 by deducting 825 shares. F2 · balance_after: Includes 1,751 shares acquired on January 31, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 22:05 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 240.3854 | $11.52 | $2,769.24 |
DisclosureSEC source: 0001415889-25-003594 · form4-02112025_100219.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,704.4391 Underlying: Common Stock · 240.3854 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 229.2417 | $12.08 | $2,769.24 |
DisclosureSEC source: 0001415889-25-002195 · form4-01282025_100148.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,464.0537 Underlying: Common Stock · 229.2417 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:45 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 242.2782 | $11.43 | $2,769.24 |
DisclosureSEC source: 0001415889-25-001428 · form4-01142025_090152.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,234.812 Underlying: Common Stock · 242.2782 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 229.6219 | $12.06 | $2,769.24 |
DisclosureSEC source: 0001415889-24-030226 · form4-12302024_091235.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,992.5338 Underlying: Common Stock · 229.6219 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 22:45 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 228.8628 | $12.10 | $2,769.24 |
DisclosureSEC source: 0001415889-24-029648 · form4-12172024_101227.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,762.9119 Underlying: Common Stock · 228.8628 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 209.6321 | $13.21 | $2,769.24 |
DisclosureSEC source: 0001415889-24-028126 · form4-12032024_101200.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,534.0491 Underlying: Common Stock · 209.6321 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 23:24 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 198.0858 | $13.98 | $2,769.24 |
DisclosureSEC source: 0001415889-24-027258 · form4-11192024_111148.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,324.417 Underlying: Common Stock · 198.0858 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:56 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 219.781 | $12.60 | $2,769.24 |
DisclosureSEC source: 0001415889-24-026163 · form4-11052024_091117.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,126.3312 Underlying: Common Stock · 219.781 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 213.5112 | $12.97 | $2,769.24 |
DisclosureSEC source: 0001415889-24-025513 · form4-10222024_081013.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,906.5502 Underlying: Common Stock · 213.5112 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 20:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 188.8977 | $14.66 | $2,769.24 |
DisclosureSEC source: 0001415889-24-024879 · form4-10082024_081046.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,693.039 Underlying: Common Stock · 188.8977 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 196.8188 | $14.07 | $2,769.24 |
DisclosureSEC source: 0001415889-24-023901 · form4-09242024_080929.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,504.1413 Underlying: Common Stock · 196.8188 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 21:37 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 183.5149 | $15.09 | $2,769.24 |
DisclosureSEC source: 0001415889-24-023164 · form4-09102024_090954.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,307.3225 Underlying: Common Stock · 183.5149 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 20:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 190.0645 | $14.57 | $2,769.24 |
DisclosureSEC source: 0001415889-24-022297 · form4-08272024_080819.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,123.8076 Underlying: Common Stock · 190.0645 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 13:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 100,000 | $13.01 | $1,300,610.00 |
DisclosureSEC source: 0001415889-24-021121 · form4-08132024_010847.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Indirect · By Revocable Trust Disclosed balance after: 145,000 F1 · shares: Reflects the weighted average price of 100,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 12, 2024 with purchase prices ranging from $12.9985 to $13.0662 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 00:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 212.365 | $13.04 | $2,769.24 |
DisclosureSEC source: 0001415889-24-021109 · form4-08132024_120843.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,933.7431 Underlying: Common Stock · 212.365 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 21:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 214.6698 | $12.90 | $2,769.24 |
DisclosureSEC source: 0001415889-24-020352 · form4-07302024_090703.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,721.3781 Underlying: Common Stock · 214.6698 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 22:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 200.5243 | $13.81 | $2,769.24 |
DisclosureSEC source: 0001415889-24-019609 · form4-07162024_100717.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,506.7083 Underlying: Common Stock · 200.5243 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 191.9085 | $14.43 | $2,769.24 |
DisclosureSEC source: 0001415889-24-018858 · form4-07022024_080742.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,306.184 Underlying: Common Stock · 191.9085 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| June 14, 2024 Filed Jun 20, 2024 20:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 153.5907 | $18.03 | $2,769.24 |
DisclosureSEC source: 0001415889-24-017610 · form4-06202024_080626.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,114.2755 Underlying: Common Stock · 153.5907 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:29 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 156.6312 | $17.68 | $2,769.24 |
DisclosureSEC source: 0001415889-24-015357 · form4-06042024_080640.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,960.6848 Underlying: Common Stock · 156.6312 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:58 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 161.096 | $17.19 | $2,769.24 |
DisclosureSEC source: 0001415889-24-013976 · form4-05212024_080520.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,804.0536 Underlying: Common Stock · 161.096 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 03, 2024 Filed May 7, 2024 20:37 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 204.6741 | $13.53 | $2,769.24 |
DisclosureSEC source: 0001415889-24-012472 · form4-05072024_080527.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,642.9576 Underlying: Common Stock · 204.6741 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:25 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 213.8409 | $12.95 | $2,769.24 |
DisclosureSEC source: 0001415889-24-011368 · form4-04232024_080437.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,438.2835 Underlying: Common Stock · 213.8409 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 20:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 177.9717 | $15.56 | $2,769.24 |
DisclosureSEC source: 0001415889-24-010565 · form4-04092024_080430.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,224.4426 Underlying: Common Stock · 177.9717 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 21:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 175.0468 | $15.82 | $2,769.24 |
DisclosureSEC source: 0001415889-24-009140 · form4-03262024_090314.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046.4709 Underlying: Common Stock · 175.0468 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:33 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 168.3429 | $16.45 | $2,769.24 |
DisclosureSEC source: 0001415889-24-007637 · form4-03122024_080324.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 871.4241 Underlying: Common Stock · 168.3429 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 00:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 11,012 | $15.99 | $176,081.88 |
DisclosureSEC source: 0001415889-24-007220 · form4-03082024_120354.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,356,455 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option(right to buy) · Derivative | 408,164 | $0.00 Strike: $16.03 | $0.00 |
DisclosureSEC source: 0001415889-24-006648 · form4-03052024_090319.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,164 Underlying: Common Stock · 408,164 shares Expires 2034-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 48,425 | $16.03 | $776,252.75 |
DisclosureSEC source: 0001415889-24-006648 · form4-03052024_090319.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,367,467 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 187,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006648 · form4-03052024_090319.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,415,892 F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 64,527 | $16.46 | $1,062,114.42 |
DisclosureSEC source: 0001415889-24-005975 · form4-02292024_110242.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,228,742 Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 148,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-005975 · form4-02292024_110242.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,293,269 F1 · balance_after: Includes 2,000 shares acquired on March 31, 2023, and 616 shares acquired on June 30, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 169.1655 | $16.37 | $2,769.24 |
DisclosureSEC source: 0001415889-24-005570 · form4-02272024_100217.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 703.0812 Underlying: Common Stock · 169.1655 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:30 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 173.4026 | $15.97 | $2,769.24 |
DisclosureSEC source: 0001415889-24-003581 · form4-02132024_100208.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 533.9157 Underlying: Common Stock · 173.4026 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 23:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 182.4269 | $15.18 | $2,769.24 |
DisclosureSEC source: 0001415889-24-001991 · form4-01302024_110156.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360.5131 Underlying: Common Stock · 182.4269 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 23:06 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 178.0862 | $15.55 | $2,769.24 |
DisclosureSEC source: 0001415889-24-001405 · form4-01172024_110123.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178.0862 Underlying: Common Stock · 178.0862 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 10, 2023 Filed Mar 13, 2023 20:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 15,000 | $9.60 | $143,971.50 |
DisclosureSEC source: 0001415889-23-004744 · form4-03132023_080325.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 45,000 F1 · price: Reflects the weighted average price of 15,000 shares of common stock of Elanco Anima Health Inc. purchased by the reporting person in multiple transactions on March 10, 2023 with purchase prices ranging from $9.585 to $9.5999 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 05, 2023 Filed Mar 8, 2023 00:47 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 10,696 | $11.10 | $118,725.60 |
DisclosureSEC source: 0001415889-23-004468 · form4-03082023_120358.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,142,569 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 9,149 | $11.01 | $100,730.49 |
DisclosureSEC source: 0001415889-23-004289 · form4-03042023_020326.xml · nonDerivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,761 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. F4 · balance_after: Balance reflects 7,127 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 23:50 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 137,882 | $11.01 | $1,518,080.82 |
DisclosureSEC source: 0001415889-23-004353 · form4-03062023_110351.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,153,265 Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 23:50 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 316,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004353 · form4-03062023_110351.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,291,147 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 567,952 | $0.00 Strike: $11.26 | $0.00 |
DisclosureSEC source: 0001415889-23-004289 · form4-03042023_020326.xml · derivative · entry 5 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,952 Underlying: Common Stock · 567,952 shares Expires 2033-03-01 F5 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 248,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004289 · form4-03042023_020326.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 991,037 F3 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.